Stay updated with breaking news from Gb Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GB Sciences (OTCMKTS:GBLX – Get Rating) is one of 357 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare GB Sciences to similar businesses based on the strength of its risk, valuation, institutional ownership, profitability, earnings, dividends and analyst recommendations. Profitability This table compares GB […]
/PRNewswire/ -- The "Global Central Nervous System Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's...
GB Sciences, Inc. (OTCMKTS:GBLX – Get Rating) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 7,400 shares, an increase of 23.3% from the March 31st total of 6,000 shares. Based on an average daily volume of 600,300 shares, the days-to-cover ratio is […]
Currently, much research is ongoing to develop new and effective therapeutic drugs for the treatment of Heart failure. The treatment of HF is dependent on angiotensin-converting enzyme inhibitor
Currently, much research is ongoing to develop new and effective therapeutic drugs for the treatment of Heart failure. The treatment of HF is dependent on...